Join
Live feed
·
PRReleasevia Quantisnow
Harmony Biosciences Holdings Inc. logo

Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
HRMY· Harmony Biosciences Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HRMY (Harmony Biosciences Holdings Inc.) and more on Quantisnow.